Peer-reviewed article

The role of esketamine in persistent long COVID with predominant psychiatric manifestations.

Bozic I iD, Ivkic D, Reinfried L, Donath J, Schmidt C iD, Graf S, Handschuh P iD, Dold M, Winkler D, Naderi-Haiden A, Praschak-Rieder N, Rujescu D, Weidenauer A iD, Bartova L iD

European neuropsychopharmacology : the journal of the European College of NeuropsychopharmacologyFeb 27, 2025Austria1 citationsDOI: 10.1016/j.euroneuro.2024.12.014

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepressionAnxiety

Keywords

FatigueEsketamineLong Covid

View paper

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022

ArticleKetamine

Integrating Ketamine and Autogenic Training for Chronic Pain: A Case Study at Walter Reed National Military Medical Center.

Carlson JG, Gbade-Alabi OA, Love DD +1

Europe PMC2026

ArticleKetamine

The Patient's Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression.

Pepe M, Bartolucci G, Marcelli I +9

Europe PMC2023